Safety and economic benefits of early hospital-at-home transfer after kidney transplantation: a propensity-score matched study from Spain.

Authors

David Cucchiari, Anna Aldea, Albert Baronet, Beatriu Bayés, Celia Cardozo, Eva Castells, Emmanuel Coloma, Fritz Diekmann, Nuria Esforzado, Nicole García-Pouton, Ángela Gonzalez-Rojas, Carlos Lopera, Mireia Musquera, Sonia Perea, Irene Pereta, Anna Pérez, Rosa Ramos, Olga Raventos, Ignacio Revuelta, Verónica Rico, Diana Rodriguez-Espinosa, Marta Sala, Nuria Seijas, Ainoa Ugarte, David Nicolás

Published in

The European journal of health economics : HEPAC : health economics in prevention and care. Jul 28, 2026. Epub Jul 28, 2026.

Abstract

Kidney transplant units worldwide face the challenge of decreasing length of hospital stay (LOHS) after transplantation, while maintaining optimal outcomes and excellence in care. The Hospital-at-Home (HaH) model has already been applied with this goal after complex surgical procedures, but evidence in solid-organ transplantation is lacking. At our Institution, we implemented a protocol for early transfer at HaH for kidney transplant recipients (KTR) starting from post-operative day 4. We report herein the outcomes of the first 100 KTRs managed with this protocol, compared with a historical cohort from a time-period (2013-2019) when the HaH protocol was not operative yet. Controls were 1:1 matched with a propensity score (PSM) using a caliper of 0.05 on 13 key donor and recipients' characteristics, type of immunosuppression and delayed graft function. Results show no differences for 1-year rejection, renal function, patient and graft survival. Importantly, patients transferred to HaH had significantly shorter median LOHS (5[4-6] versus 9[8-15] days, P < 0.001). The median duration of HaH admission was 5[3-11] days. The combined duration of hospital plus HaH admission in the modern cohort (10[8-18] days) was not different from historical cohort LOHS (P = 0.117). Readmission rates at 30 and 90 days were similar between groups. This optimized management translated into lower costs of the HaH cohort (31874 ± 9114 versus 35780 ± 15720€, P = 0.033) for the whole transplantation process, mainly driven by reduced ward stay and in-hospital medication. We conclude that, in our experience, early transfer to HaH after transplantation optimized health-associated resources, while maintaining adequate clinical outcomes.

PMID:
42518093
Bibliographic data and abstract were imported from PubMed on 28 Jul 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.